Transcat FY2026 EPS Forecast Decreased by Northland Capmk

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Equities researchers at Northland Capmk reduced their FY2026 earnings estimates for Transcat in a research report issued on Wednesday, June 4th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will post earnings per share of $2.00 for the year, down from their prior estimate of $2.37. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat's FY2027 earnings at $2.24 EPS, FY2028 earnings at $2.57 EPS, FY2029 earnings at $2.92 EPS and FY2030 earnings at $3.30 EPS.

Several other analysts also recently commented on TRNS. HC Wainwright reissued a "buy" rating and set a $116.00 price objective (up from $106.00) on shares of Transcat in a research report on Wednesday, May 21st. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $114.00.

Transcat Stock Up 2.4%

Shares of TRNS traded up $1.83 during trading hours on Monday, hitting $77.39. The company had a trading volume of 158,186 shares, compared to its average volume of 85,998. The stock has a market capitalization of $721.12 million, a price-to-earnings ratio of 41.83 and a beta of 0.75. The firm has a fifty day moving average price of $82.28 and a 200-day moving average price of $87.67. Transcat has a 52-week low of $67.56 and a 52-week high of $147.12. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. The company's revenue for the quarter was up 8.8% compared to the same quarter last year.

Hedge Funds Weigh In On Transcat

A number of hedge funds have recently bought and sold shares of TRNS. Jones Financial Companies Lllp boosted its holdings in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after acquiring an additional 309 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Transcat in the first quarter worth approximately $76,000. Aquatic Capital Management LLC boosted its holdings in Transcat by 1,052.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,052 shares during the last quarter. State of Wyoming bought a new stake in Transcat in the 1st quarter worth approximately $95,000. Finally, Morgan Dempsey Capital Management LLC purchased a new stake in Transcat during the 4th quarter valued at $143,000. Hedge funds and other institutional investors own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.